About Smith and Kenner Pharmaceuticals Pvt Ltd
Data last updated:
Smith and Kenner Pharmaceuticals Pvt Ltd is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1987PTC007087. Its GSTIN is 36AACCS8118A1ZO (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2.6 Cr and a paid-up capital of ₹2.12 Cr. It is led by directors Jayswamy Sesham (Managing Director) and Sobha Sesham.
Its last annual general meeting (AGM) was held on 01 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 16 – 2 – 789/F/4 Asmangadhmalakpet Hyderabad, Telangana, India – 500036.
As per the financials filed for FY 2026, the company reported a revenue of ₹9.79 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.23 Lakh (net margin 0.1%) and EBITDA of ₹12.32 Lakh (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 102% over five years.
As per MCA filings, the company has open charges of ₹4.39 Cr on record. Court records list 25 cases involving the company, including 11 filed by the company and 14 filed against it; 11 cases are pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website smithkenner.com.
Company details
CIN history
Smith and Kenner Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230AP1987PTC007087. The current CIN is U24230TG1987PTC007087, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1987PTC007087 | Current |
| U24230AP1987PTC007087 | Previous |
Contact details
Smith and Kenner Pharmaceuticals Pvt Ltd's registered office is in Hyderabad, Telangana. Its website is smithkenner.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address16 – 2 – 789/F/4 Asmangadhmalakpet Hyderabad, Telangana, India – 500036
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Smith and Kenner Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Smith and Kenner Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Smith and Kenner Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Smith and Kenner Pharmaceuticals Pvt Ltd
FY 2026 filings availableSmith and Kenner Pharmaceuticals Pvt Ltd reported revenue of ₹9.79 Cr (up 202% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 102% over five years, including 202% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹9.79 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.32 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Smith and Kenner Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Smith and Kenner Pharmaceuticals Pvt Ltd
Smith and Kenner Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayswamy Sesham | Managing Director | 09 Jan 1987 | 39 Years 10 Months | Current |
| Sobha Sesham | Director | 09 Jan 1987 | 39 Years 10 Months | Current |
Auditor
Smith and Kenner Pharmaceuticals Pvt Ltd is audited by JOSEPHMANOHARMESA for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JOSEPHMANOHARMESA | FY 2026 | 206612 |
Shareholding
The shareholding of Smith and Kenner Pharmaceuticals Pvt Ltd is on record for 4 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Smith and Kenner Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 May 2001 | 90117654 | A.P.S.F.C. | ₹6 Lakh | Open | |
| 13 Aug 1991 | 90116830 | State Bank of India | ₹15 Lakh | Open | |
| 25 Mar 1990 | 90119401 | State Bank of India | ₹5 Lakh | Open | |
| 26 Aug 1988 | 80063524 | State Bank of India | ₹3.83 Cr | Open | |
| 26 Aug 1988 | 90116645 | State Bank of India | ₹15 Lakh | Open |
To see the full charge records of Smith and Kenner Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 6 View all charges
Legal cases
Smith and Kenner Pharmaceuticals Pvt Ltd has 25 court cases on record: 11 filed by Smith and Kenner Pharmaceuticals, 14 filed against it. 11 cases are pending and 14 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 15 | 9 | 7 |
| High courts | 10 | 5 | 4 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (COS) | Filed by the company against M/S. Aspen Biopharma Labs Pvt Ltd | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Signature Pharmaceuticals Limited and 1 other | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Magma Fincorp Limited | Pending |
| District court, Hyderabad Central, Telangana | Civil suit | Filed by the company against M/S. Aspen Biopharma Labs Pvt Ltd and 2 others | Disposed |
| District court, Rangareddy, Telangana | Court case (STC-NI) | Filed by the company against Aspen Biopharma Labs Pvt Ltd and 2 others | Disposed |
To see the full case history of Smith and Kenner Pharmaceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Smith and Kenner Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Smith and Kenner Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCS8118A1ZO | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Smith and Kenner Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Smith and Kenner Pharmaceuticals Pvt Ltd has 2 board changes on record since 1987: 2 appointments. The latest: Jayswamy Sesham was appointed as Managing Director on 09 Jan 1987.
4 earlier events are in the company report.
Frequently asked questions
Smith and Kenner Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 1987 (39+ years old) and is registered under CIN U24230TG1987PTC007087.
Smith and Kenner Pharmaceuticals has 2 current directors:
- Jayswamy Sesham - Managing Director
- Sobha Sesham - Director
The latest financial statements of Smith and Kenner Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 01 June 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Smith and Kenner Pharmaceuticals is 36AACCS8118A1ZO, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Smith and Kenner Pharmaceuticals is U24230TG1987PTC007087. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Smith and Kenner Pharmaceuticals has 25 court cases on record: 11 filed by the company and 14 filed against it. 11 are pending. Most are in the district courts.
Smith and Kenner Pharmaceuticals was incorporated on 09 January 1987, making it 39+ years old. It is registered with the Registrar of Companies, Hyderabad.
Jayswamy Sesham was appointed as Managing Director on 09 Jan 1987. Sobha Sesham was appointed as Director on 09 Jan 1987.
Smith and Kenner Pharmaceuticals can be reached through the website smithkenner.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Smith and Kenner Pharmaceuticals is at 16 – 2 – 789F4 Asmangadhmalakpet Hyderabad, Telangana, India – 500036.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
